Century-old vaccine protects type 1 diabetics from infectious diseases
Science Daily
Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1..
Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1..
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "BCG Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and..
[The Conversation Africa] The BCG vaccine for TB has been used for 100 years. It is largely effective for children under five, but..